OLIG2 and glioblastoma: Our results indicate that the biomarker set integrated by EGFR, H3F3A, FLT1, MGMT, MKi67, NES, S100A, TP53, OLIG2 and VIM genes could be a strong combination to determine the GBM molecular subtype (figure 6).